Detalhe da pesquisa
1.
Changes in PBM Business Practices in 2019: True Innovation or More of the Same?
J Manag Care Spec Pharm
; 26(10): 1325-1333, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869706
2.
Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population.
Am J Manag Care
; 11(1): 29-36, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15697098
3.
Is value-based value wasted? Examining value-based insurance designs through the lens of cost-effectiveness.
J Manag Care Pharm
; 16(2): 130-3, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20178398
4.
Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products.
J Manag Care Spec Pharm
; 21(1): 23-34, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25562770
5.
Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.
Clin Ther
; 25(12): 3147-61; discussion 3144-6, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14749153
6.
Plan-sponsor savings and member experience with point-of-service prescription step therapy.
Am J Manag Care
; 10(7 Pt 1): 457-64, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15298367
7.
Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s).
Am J Manag Care
; 9(12): 785-94, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14712755
8.
Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy.
Am J Manag Care
; 9(11): 735-42, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14626471
9.
Predictors of satisfaction of health plan members with prescription drug benefits.
Am J Health Syst Pharm
; 61(10): 1007-14, 2004 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15160776
10.
Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002.
Psychiatr Serv
; 55(4): 387-91, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15067149
11.
Do decision-analytic models identify cost-effective treatments? A retrospective look at helicobacter pylori eradication.
J Manag Care Pharm
; 9(5): 430-40, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14613441
12.
Health plan member experience with point-of-service prescription step therapy.
J Manag Care Pharm
; 10(4): 291-8, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15298527
13.
Randomized controlled trial of a dose consolidation program.
J Manag Care Pharm
; 10(5): 396-403, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15369422
14.
2008: a tipping point for disease management?
J Manag Care Pharm
; 14(7): 643-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18774874
15.
Pharmaceutical step-therapy interventions: a critical review of the literature.
J Manag Care Pharm
; 17(2): 143-55, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21348547
16.
Telephone-based disease management: why it does not save money.
Am J Manag Care
; 17(1): e10-6, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21485420
17.
Assessing the value of the Quality of Health Economic Studies (QHES).
J Manag Care Pharm
; 9(1): 86-7, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14613368
18.
Gender- and age-related prescription drug use patterns.
Ann Pharmacother
; 36(1): 30-9, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11816254
19.
Use of chronic medications among a large, commercially-insured US population.
Pharmacoepidemiol Drug Saf
; 11(4): 301-9, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12138598
20.
Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample.
Pediatrics
; 111(2): 237-43, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12563045